Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
09/2012
09/19/2012CN102106925B Medlar polysaccharide and bifidobacterium synbiotic colonic targeting microecological regulator
09/19/2012CN102058531B Preparation method of fat emulsion of cerebral protection therapeutic drug
09/19/2012CN101947320B Mesoporous silicon/polymer composite controlled release medicament carrier, preparation method and application thereof
09/19/2012CN101947309B Human basic fibroblast growth factor eye drops and preparation method thereof
09/19/2012CN101904841B Phenylphthalimide analog and its application for preparing diabetic macular edema drugs
09/19/2012CN101810582B Method for preparing veterinary tilmicosin microspheres
09/19/2012CN101744820B Medicine composite containing dextromethorphan hydrobromide
09/19/2012CN101641091B Tamibarotene capsule preparation
09/19/2012CN101537037B Amaranth berberine tablet and preparation method thereof
09/19/2012CN101480397B Cefixime orally disintegrating tablet and preparation method thereof
09/19/2012CN101472573B Reduced coenzyme Q10-containing composition and method for producing the same
09/19/2012CN101297968B Preparation of pig serum immunoglobulin microsphere novel dosage form
09/19/2012CN101268118B Method for preparing polymer maleimides
09/19/2012CN101219115B Sustained drug-release particles and process for producing the same
09/19/2012CN101166763B Stabilized anti-hepatitis B (HBV) antibody formulations
09/19/2012CN101060792B Modified plant gums for preparations of active ingredients
09/19/2012CN101027077B Ejection liquid, ejection device, ejection cartridge, and method of making droplets from liquid
09/18/2012US8269040 O-desmethylvenlafaxine succinate; tablet, capsule; sustained release; hydroxypropylmethyl cellulose rate controlling polymer; microcrystalline cellulose binder; depression, bipolar and manic disorders, attention deficit disorder, attention deficit disorder with hyperactivity, Parkinson's disease
09/18/2012US8268986 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
09/18/2012US8268790 Dermatalogical formulations
09/18/2012US8268782 Composition and method for preparing plasminogen
09/18/2012US8268358 Use of simple amino acids to form porous particles
09/18/2012US8268351 time-release agents comprising water-swellable matrix cores containing estrogen derivative extracted from animals surrounded by film-forming coatings
09/18/2012US8268341 Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
09/18/2012US8268333 Orally administered agent and an orally administered agent/supporting substrate complex
09/18/2012US8268322 Polypeptide specifically binding to vascular endothelial growth factor, fusion protein including polypeptide, and methods therefor
09/18/2012US8268319 Immunoconjugates with an intracellularly-cleavable linkage
09/18/2012US8268312 Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
09/18/2012US8268305 Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase
09/18/2012US8268240 Ciclesonide-containing sterile aqueous suspension
09/18/2012CA2669913C Endoxifen methods and compositions
09/18/2012CA2616589C Compositions for the reversible thioesterification of signaling proteins and methods of using same
09/18/2012CA2549516C Percutaneous absorption-type pharmaceutical preparation
09/18/2012CA2533321C Bicyclic peptide imaging agents
09/18/2012CA2528431C Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen
09/18/2012CA2523735C Thickenable compositions
09/18/2012CA2507002C Solid drug for oral use
09/18/2012CA2493604C Patch containing fentanyl for mucous membrane of oral cavity
09/18/2012CA2492156C Tablet composition containing kampo medicinal extract and its manufacturing process
09/18/2012CA2480226C Stable pharmaceutical composition containing factor viii
09/18/2012CA2479659C Choline-silicic acid complex with osmolytes and divalent trace elements
09/18/2012CA2477288C Biodegradable polymeric material for biomedical applications
09/18/2012CA2461896C Injections for eye tissues containing drug bonded to polyethylene glycol
09/18/2012CA2405731C Compositions and methods for improving vascular health
09/18/2012CA2405345C Joint repair using mesenchymal stem cells
09/18/2012CA2388733C Food supplement for increasing lean mass and strength
09/18/2012CA2226013C Preparations and methods for the treatment of t cell mediated diseases
09/13/2012WO2012122544A2 Protein nanoparticle dispersions
09/13/2012WO2012122471A2 Compounds and methods of use in ablative radiotherapy
09/13/2012WO2012121971A2 Locally released growth factors to mediate motor recovery after stroke
09/13/2012WO2012121758A1 Melt-extruded solid dispersions containing an apoptosis-inducing agent
09/13/2012WO2012121528A2 Magnetic nanocomposite specific for thyroid cancer and use thereof
09/13/2012WO2012121395A1 Cholesterol-dependent cytolysin variant and use thereof in dds
09/13/2012WO2012121202A1 Tablet-type composition for oral administration and method for producing same
09/13/2012WO2012121094A1 Albumin-containing intravenous injection
09/13/2012WO2012120522A1 A taste masked chewable tablet of sildenafil
09/13/2012WO2012120516A1 Soy protein-based structures and uses thereof
09/13/2012WO2012120366A1 Novel moisture barrier immediate release film coating composition
09/13/2012WO2012120365A1 Stable pharmaceutical composition comprising ethinyl estradiol
09/13/2012WO2012120139A1 Implantable bio-resorbable polymer charged with fragile macromolecules
09/13/2012WO2012119997A1 Pharmaceutical formulation for producing rapidly disintegrating tablets
09/13/2012WO2012119980A1 Particles containing a growth factor, and uses thereof
09/13/2012WO2012119972A1 Conjugation process
09/13/2012WO2012119787A1 Amatoxin-conjugates with improved linkages
09/13/2012WO2012119261A1 Enhanced artificial mucus composition comprising hyaluronan for the treatment of rhinitis
09/13/2012WO2012103444A3 Immunogenic compositions and reagents for preparing
09/13/2012WO2012087962A3 Anti-mesothelin antibodies and immunoconjugates
09/13/2012WO2011140086A3 Serum albumin binding molecules
09/13/2012WO2011131203A3 A solid pharmaceutical composition for neutralizing stomach acid
09/13/2012WO2011005540A8 Methods and compositions using peptides and proteins with c-terminal elements
09/13/2012US20120233728 Lipid layer forming composition for administration onto a surface of a living organism
09/13/2012US20120232169 Highly monodisperse branched peg-lipid conjugates
09/13/2012US20120232167 Hydroxyalkylcellulose microparticles
09/13/2012US20120232166 Masking Bitter Flavors
09/13/2012US20120232164 Fibrous calcium pyrophosphate particles and methods of making and using same
09/13/2012US20120232157 Methods of using derivatives of (-)-venlafaxine
09/13/2012US20120231093 Method for preparing nano-scale or amorphous particle using solid fat as a solvent
09/13/2012US20120231086 Protein matrix vaccines of improved immunogenicity
09/13/2012US20120231075 Abuse-resistant opioid dosage form
09/13/2012US20120231072 Thermo-responsive hydrogel compositions
09/13/2012US20120231071 Natural product inhibitors of 3dg
09/13/2012US20120231062 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
09/13/2012US20120231061 Long term drug delivery devices with polyurethane-based polymers and their manufacture
09/13/2012US20120231054 Use of an oleogel containing triterpene for healing wounds
09/13/2012US20120231047 Therapeutic agent delivery for the treatment of asthma via implantable and insertable medical devices
09/13/2012US20120231042 Pharmaceutical Formulation For Producing Rapidly Disintegrating Tablets
09/13/2012US20120231039 Chimeric immunomodulatory compounds and methods of using the same-iv
09/13/2012US20120231038 Wound Healing Compositions Comprising Biocompatible Cellulose Hydrogel Membranes and Methods of Use Thereof
09/13/2012US20120231022 Glp-1 receptor agonist compounds for sleep enhancement
09/13/2012US20120230937 Implantable bio-resorbable polymer
09/13/2012US20120230928 Compositions of active ingredients
09/13/2012US20120230922 Novel Polymorphs of Rebaudioside C and Methods for Making and Using the Same
09/13/2012US20120230917 Compositions that include a hydrophobic compound and a polyamino acid conjugate
09/13/2012US20120228520 Photoregulated Reversible Hydrogels for Delivery and Releasing of Drugs and Other Therapeutical Reagents
09/13/2012CA2829629A1 Protein nanoparticle dispersions
09/13/2012CA2829558A1 Pi3 kinase inhibitors and uses thereof
09/13/2012CA2829421A1 Amatoxin-conjugates with improved linkages
09/13/2012CA2829367A1 Non-aqueous high concentration reduced viscosity suspension formulations of antibodies
09/13/2012CA2829217A1 Compounds and methods of use in ablative radiotherapy
09/13/2012CA2829006A1 Locally released growth factors to mediate motor recovery after stroke
1 ... 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 ... 1712